Suggestions
Lenny Moise
Director of Vaccine Research at EpiVax
Professional Background
Dr. Lenny Moise is a highly regarded figure in the field of vaccine research, currently serving as the Director of Vaccine Research at EpiVax, Inc. His illustrious career includes a significant academic role as an Associate Research Professor at the University of Rhode Island. Additionally, Dr. Moise has contributed to the Center for Vaccines and Immunology at the University of Georgia as a Research Professor since 2020. Throughout his career, he has demonstrated a steadfast commitment to advancing the science of immunology and vaccine development, focusing particularly on T-cell epitope-driven approaches.
Dr. Moise embarked on his academic journey at Brown University, where he pursued his PhD in Molecular and Cellular Biology and Biochemistry, culminating in a degree awarded in 2002. Under the guidance of Dr. Edward Hawrot, he conducted pivotal research that examined the intricate structure-function relationships of snake neurotoxin interactions with nicotinic acetylcholine receptors. This foundational work not only honed his skills in the laboratory but also paved the way for future research endeavors.
After completing his PhD, Dr. Moise undertook postdoctoral training at Brown University, where he engaged in functional analysis of toxin binding sites engineered into toxin-insensitive ion channels. His postdoctoral work further deepened his understanding of molecular interactions and set the stage for his subsequent contributions to the field of immunology.
In 2005, he took a significant step in his career by joining Dr. Anne De Groot’s laboratory at Brown University as an Instructor in Medicine within the Department of Medicine (Infectious Disease). Here, he focused on pivotal research in T-cell epitope-driven vaccination and the immunogenicity of protein therapeutics, highlighting the importance of T-cell responses in developing effective vaccines.
Since 2006, Dr. Moise has been a part of EpiVax, Inc., a biotech company dedicated to revolutionizing vaccine design. As the Director of Vaccine Research, he spearheads projects that leverage a genomes-to-vaccine approach, integrating state-of-the-art immunoinformatics and immunologic methodologies to develop innovative vaccine candidates. His current research further includes the de-immunization of protein therapeutics through targeted epitope modifications, an essential area of study in optimizing protein-based therapies and enhancing patient safety.
In addition to his role at EpiVax, Dr. Moise has maintained a robust academic presence. His part-time appointment as an Assistant Research Professor in the Department of Cell and Molecular Biology at the University of Rhode Island, which began in 2008, underscores his dual commitment to research and education. As a founding faculty member of the URI Institute for Immunology and Informatics, he leads numerous vaccine and immunotherapeutic development projects, contributing significantly to educational advancements in immunology.
Dr. Moise's contributions to the scientific community extend beyond his research and teaching roles. He has published over 80 manuscripts and reviews, marking his impact on the field through scholarly work that shares knowledge and insights with peers worldwide. His research has garnered funding from reputable organizations including the National Institutes of Health (NIH), American Thyroid Association, and Rhode Island Foundation.
Education and Achievements
Dr. Lenny Moise's academic foundation is solidly grounded in biochemistry, holding both a Bachelor of Science (ScB) and a Doctor of Philosophy (PhD) from Brown University. This extensive educational background has equipped him with a profound understanding of molecular biology and biochemistry, integral to his pursuits in vaccine research.
Dr. Moise's achievements are numerous, including his active role in pioneering innovative vaccine technologies and contributing to the understanding of immune responses to various pathogens. He has a diverse range of research interests that span immunoinformatics, immunogenicity, and T-cell epitope design. His lab is at the forefront of efforts to create safer and more effective vaccines, employing cutting-edge techniques.
Throughout his career, Dr. Moise has been recognized for his dedication to advancing vaccine science. His work's collaborative nature is demonstrated through partnerships with governmental and private entities to secure funding, fostering advancements that can translate into real-world applications in immunotherapy and vaccine design.
Achievements
Some notable achievements in Dr. Lenny Moise's career include:
- Director of Vaccine Research at EpiVax: Leading innovative projects in vaccine development since 2006, focusing on T-cell epitope-driven methodologies that embrace genomics and immunology.
- Research Professor at the University of Georgia: Contributing to cutting-edge research and training the next generation of scientists in immunology.
- Founding Faculty Member of the URI Institute for Immunology and Informatics: Acknowledged for key contributions to the foundation of this institute, aimed at advancing immunological research and education.
- Published Author: With over 80 research articles and review papers, Dr. Moise has played a crucial role in sharing his findings and educating others in the field of vaccine research and immunology.
- Secured Research Funding: Successfully received grants from esteemed organizations, demonstrating a high level of trust and recognition within the scientific community.
In summary, Dr. Lenny Moise's extensive background in vaccine research, combined with his dedication to teaching and mentorship, exemplifies the qualities of a leader in the field of immunology. His innovative approach to vaccine development, alongside his commitment to education and research dissemination, positions him as a significant contributor to the ongoing fight against infectious diseases.